Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization

被引:0
|
作者
Nikolas Friedrich
Emanuel Stiegeler
Matthias Glögl
Thomas Lemmin
Simon Hansen
Claus Kadelka
Yufan Wu
Patrick Ernst
Liridona Maliqi
Caio Foulkes
Mylène Morin
Mustafa Eroglu
Thomas Liechti
Branislav Ivan
Thomas Reinberg
Jonas V. Schaefer
Umut Karakus
Stephan Ursprung
Axel Mann
Peter Rusert
Roger D. Kouyos
John A. Robinson
Huldrych F. Günthard
Andreas Plückthun
Alexandra Trkola
机构
[1] University of Zurich (UZH),Institute of Medical Virology
[2] ETH Zurich,Department of Computer Science
[3] University of Zurich (UZH),Department of Biochemistry
[4] Iowa State University,Department of Mathematics
[5] University of Zurich (UZH),Department of Chemistry
[6] University Hospital Zurich (USZ),Division of Infectious Diseases and Hospital Epidemiology
[7] Roche Diagnostics GmbH,Euler Institute, Faculty of Biomedicine
[8] Università della Svizzera italiana (USI),Office Research and Teaching, Medical Faculty
[9] NGM Bio,Laboratory Medicine, Division of Clinical Chemistry
[10] 333 Oysterpoint Blvd,undefined
[11] Innovent Biologics Inc,undefined
[12] University of Zurich,undefined
[13] BeiGene Switzerland GmbH,undefined
[14] Janssen Vaccines AG,undefined
[15] ImmunoTechnology Section,undefined
[16] Vaccine Research Center,undefined
[17] NIAID,undefined
[18] NIH,undefined
[19] University Hospital Basel,undefined
[20] Novartis Institutes for BioMedical Research,undefined
[21] Chemical Biology & Therapeutics (CBT),undefined
[22] Novartis Pharma AG,undefined
[23] University of Cambridge School of Clinical Medicine,undefined
[24] Department of Radiology,undefined
[25] Roche Innovation Center Zurich,undefined
[26] Roche Pharmaceutical Research and Early Development (pRED),undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The V3 loop of the HIV-1 envelope (Env) protein elicits a vigorous, but largely non-neutralizing antibody response directed to the V3-crown, whereas rare broadly neutralizing antibodies (bnAbs) target the V3-base. Challenging this view, we present V3-crown directed broadly neutralizing Designed Ankyrin Repeat Proteins (bnDs) matching the breadth of V3-base bnAbs. While most bnAbs target prefusion Env, V3-crown bnDs bind open Env conformations triggered by CD4 engagement. BnDs achieve breadth by focusing on highly conserved residues that are accessible in two distinct V3 conformations, one of which resembles CCR5-bound V3. We further show that these V3-crown conformations can, in principle, be attacked by antibodies. Supporting this conclusion, analysis of antibody binding activity in the Swiss 4.5 K HIV-1 cohort (n = 4,281) revealed a co-evolution of V3-crown reactivities and neutralization breadth. Our results indicate a role of V3-crown responses and its conformational preferences in bnAb development to be considered in preventive and therapeutic approaches.
引用
收藏
相关论文
共 50 条
  • [41] Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations
    Huisman, JG
    Carotenuto, A
    Labrijn, AF
    Papavoine, CHM
    Laman, JD
    Schellekens, MM
    Koppelman, MHGM
    Hilbres, CW
    BIOCHEMISTRY, 2000, 39 (35) : 10866 - 10876
  • [42] V3 SEQUENCES IN PRIMARY HIV-1 INFECTION
    ANTONIOLI, IM
    BAUMBERGER, C
    YERLY, S
    PERRIN, L
    AIDS, 1995, 9 (01) : 11 - 17
  • [43] Effects of mutations on HIV-1 infectivity and neutralization involving the conserved NNNT amino acid sequence in the gp120 V3 loop
    Polzer, Svenja
    Mueller, Harm
    Schreiber, Michael
    FEBS LETTERS, 2009, 583 (07): : 1201 - 1206
  • [44] Role of gp120 V3 loop charge in HIV-1 coreceptor selectivity
    Lopez de Victoria, Aliana
    Kieslich, Chris A.
    Shin, David
    Tamamis, Phanourios
    Gonzalez-Rivera, Gloria
    Morikis, Dimitrios
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [45] Sequence variation and consensus sequence of V3 loop on HIV-1 gp120
    Tian, HJ
    Lan, CH
    Chen, YH
    IMMUNOLOGY LETTERS, 2002, 83 (03) : 231 - 233
  • [46] ANTIBODY-RESPONSES RAISED AGAINST A CONFORMATIONAL V3 LOOP PEPTIDE OF HIV-1
    BUKAWA, H
    FUKUSHIMA, J
    HAMAJIMA, K
    KIMURA, M
    TSUJI, T
    XIN, KQ
    OKUDA, K
    MICROBIOLOGY AND IMMUNOLOGY, 1995, 39 (08) : 607 - 614
  • [47] DIVERGENCE OF HIV-1 IN V3 LOOP SEQUENCES IN GENETICALLY IDENTICAL-TWINS AND THEIR MOTHER
    CARTAS, MA
    MONKEN, CE
    MURRAY, MF
    THOMAS, CY
    SAULSBURY, FT
    PUDLOSKY, SA
    SRINIVASAN, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S41 - S41
  • [48] STRUCTURE-FUNCTION ANALYSIS OF THE HIV-1 V3 ENVELOPE LOOP TROPISM DETERMINANT
    RATNER, L
    CARRILLO, A
    EBENBICHLER, C
    GU, R
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S72 - S72
  • [49] STRUCTURE-FUNCTION-RELATIONSHIPS OF THE HIV-1 ENVELOPE V3 LOOP TROPISM DETERMINANT
    RATNER, L
    CARRILLO, A
    EBENBICHLER, C
    GU, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 54 - 54
  • [50] TRENDS IN V3 LOOP SEQUENCES AMONG 5 MAJOR HIV-1 GENETIC LINEAGES
    KORBER, B
    SMITH, R
    MACINNES, K
    MYERS, G
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S55 - S55